Arcadia Wealth Management (New York)’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281K Hold
209,972
0.15% 45
2025
Q4
$514K Hold
209,972
0.3% 32
2025
Q3
$1.41M Hold
209,972
0.86% 24
2025
Q2
$1.23M Hold
209,972
0.84% 26
2025
Q1
$1.76M Buy
+209,972
New +$1.89M 1.37% 18

Other funds holding TMCI

Arcadia Wealth Management (New York)'s TMCI Position: Q1 2026 in Review

Arcadia Wealth Management (New York) held its Treace Medical Concepts (TMCI) position steady in Q1 2026 at 209,972 shares worth $281K. The position accounts for 0.15% of the portfolio, ranked #45.

Arcadia Wealth Management (New York) first reported a position in TMCI in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.76M in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Arcadia Wealth Management (New York) held 209,972 shares of Treace Medical Concepts worth $281K as of Q1 2026.
  • Arcadia Wealth Management (New York) left its Treace Medical Concepts share count unchanged in Q1 2026.
  • Treace Medical Concepts made up 0.15% of Arcadia Wealth Management (New York)'s portfolio in Q1 2026, its #45 holding.
  • Arcadia Wealth Management (New York) first reported a position in Treace Medical Concepts in Q1 2025 and has held it in 5 quarters since.
  • Arcadia Wealth Management (New York)'s Treace Medical Concepts position peaked at $1.76M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Arcadia Wealth Management (New York)'s 13F filing for Q1 2026, filed 14 May 2026.